Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.

Abstract

In this open-label study, patients with distal UC who were refractory to all previous therapy had a 40% complete response rate and an overall 60% response rate. Controlled studies of this promising therapy are indicated.